Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Cost-Effectiveness and Budget Impact Analysis of Radiofrequency Renal Denervation for Uncontrolled and Resistant Hypertension in Italy.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same author

Aldosterone synthase inhibitors in uncontrolled and resistant hypertension: promise, pitfalls, and unanswered questions.

European journal of internal medicine·2026
Same author

Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.

Journal of hypertension·2026
Same author

Hypertension in autoimmune rheumatic diseases - a position paper from the European Society of Hypertension working group on small arteries. Part B: Recommendations for the clinical management of hypertension.

Journal of hypertension·2026
Same author

BET-induced metabolic reprogramming fuels inflammation at the vascular-fat interface in mice and patients with cardiometabolic disease.

Cell reports·2026
Same author

The QUADRO trial: a regulatory study with rigorous design and robust evidence.

European heart journal·2026

Related Experiment Videos

Fixed-dose combination therapy in hypertension: pros.

Stefano Taddei1

  • 1Department of Internal Medicine, University of Pisa, Pisa, Italy. stefano.taddei@med.unipi.it

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|August 8, 2012
PubMed
Summary

Combination therapies, particularly those involving angiotensin II receptor blockers, improve blood pressure control and cardiovascular protection in hypertensive patients. This approach offers better tolerability and adherence than monotherapy, reducing risks associated with poorly managed hypertension.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Hypertension control is crucial for preventing cardiovascular diseases like myocardial infarction and stroke.
  • Despite established treatments, hypertension remains poorly controlled globally, leaving patients at elevated cardiovascular risk.
  • Treated hypertensive patients often face higher risks due to unaddressed cardiovascular risk profiles.

Purpose of the Study:

  • To explore combination therapies as an emerging strategy for improved blood pressure control in hypertension.
  • To evaluate the efficacy and safety of specific drug combinations for cardiovascular disease prevention.
  • To compare the benefits of angiotensin II receptor blockers (ARBs) in combination therapy versus ACE inhibitors.

Main Methods:

  • Review of antihypertensive drug combinations, focusing on renin-angiotensin system inhibitors, thiazide diuretics, and calcium channel blockers.
  • Analysis of randomized controlled clinical trials comparing ARBs with ACE inhibitors for hypertension management.
  • Assessment of tolerability, adherence, and cardiovascular protection offered by different therapeutic strategies.

Main Results:

  • Combination therapies, especially those involving ARBs, demonstrate effective systolic and diastolic blood pressure reduction.
  • ARBs show superior tolerability and greater cardiovascular protection against organ damage compared to ACE inhibitors.
  • Rational combination therapies improve adherence and reduce treatment discontinuations in hypertensive patients.

Conclusions:

  • Combination antihypertensive therapy is a promising strategy, particularly as a first-line treatment for high-risk patients.
  • Angiotensin II receptor blockers offer significant advantages in tolerability and cardiovascular protection within combination regimens.
  • Optimized combination therapies are key to improving blood pressure control and reducing cardiovascular events in hypertension.